Form D · Biotechnology
Pneumeric, Inc.
Rochester, MN · CIK 0001892733
Offering snapshot reported Nov 30, 2023 · SEC filing
- Reported sold
- Yet to sell Offering amount: $3.5M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 30, 2023 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Jul 25, 2023 | Amendment | $2,218,899 | $1,260,399vs Nov 14, 2022 | 23 | SEC filing |
| Nov 14, 2022 | Amendment | $958,500 | $658,500vs Nov 12, 2021 | 14 | SEC filing |
| Nov 12, 2021 | Initial | $300,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-498498
Total Amount Sold includes the conversion of approximately $2,500,000 in previously issued convertible notes and accrued interest.
Source: Form D, filed Nov 30, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Johnathon Aho | Director, Executive, Promoter |
| Sasha Gentling | Director, Promoter |
| Jonathan Sackner Bernstein | Director, Executive |
| Marsha Timmerman | Director |
| Todd Wiltshire | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
823 4th Street Sw
Rochester, MN, 55902
Rochester, MN, 55902